Cassava Sciences, Inc

At close
No trades
See on super-charts

Key stats

Market capitalization
1.099BUSD
Dividends yield (FY)
Price to earnings Ratio (TTM)
Basic EPS (TTM)
−1.90USD

About Cassava Sciences, Inc

ISIN
US14817C1071
CEO
Remi Barbier
Headquarters
Austin
Employees
26
Founded
1998

Cassava Sciences, Inc. engages in the development of novel drugs and diagnostics. It focuses on developing product candidates intended for the treatment of Alzheimer’s disease, including PTI-125 and PTI-125Dx. The company was founded by Remi Barbier in May 1998 and is headquartered in Austin, TX.

Summarizing what the indicators are suggesting.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
An aggregate view of professional's ratings.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Income Statement
Balance Sheet
Cash Flow
Earnings
Next:
Revenue

Explore more features and data

Learn more about our full range of powerful features including the best charts on the web.Learn more